Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts.

Abstract

Authors

• Sarah Haggenmüller
  Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
• Roman C Maron
  National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
• Achim Hekler
  National Center for Tumor Diseases, Department of Translational Oncology, German Cancer Research Center, Heidelberg, Germany.
• Jochen S Utikal
  Department of Dermatology, Heidelberg University, Mannheim, Germany; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• Catarina Barata
  Institute for Systems and Robotics (ISR/IST), Instituto Superior Técnico, University of Lisbon, Portugal.
• Raymond L Barnhill
  Departments of Pathology and Translational Research, Institut Curie, Paris, France.
• Helmut Beltraminelli
  Department of Dermatology, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.
• Carola Berking
  Department of Dermatology, University Hospital Munich, Ludwig Maximilian University of Munich, Munich, Germany.
• Brigid Betz-Stablein
  QIMR Berghofer Medical Research Institute, Cancer and Population Studies, Brisbane, Queensland, Australia.
• Andreas Blum
• Stephan A Braun
  Department of Dermatology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany; Department of Dermatology, University Hospital Münster, Germany.
• Richard Carr
  Department of Pathology, Warwick Hospital, Warwick, UK.
• Marc Combalia
  Department of Dermatology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Ciber de Enfermedades Raras ISCIII, Barcelona, Spain.
• Maria-Teresa Fernandez-Figueras
  Hospital Universitari General de Catalunya, Grupo Quironsalud, Universitat Internacional de Catalunya, Sant Cugat Del Vallés, Barcelona, Spain.
• Gerardo Ferrara
  Anatomic Pathology Unit, Macerata General Hospital, Macerata, Italy.
• Sylvie Fraitag
  Department of Pathology, University Paris Descartes, Necker-Enfants Malades Hospital, Assistance Publique Hospitals of Paris, Paris, France.
• Lars E French
  Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.
• Frank F Gellrich
  Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
• Kamran Ghoreschi
  Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• Matthias Goebeler
  Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.
• Pascale Guitera
  Sydney Melanoma Diagnostic Centre, Faculty of Medicine and Health, Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia.
• Holger A Haenssle
  Department of Dermatology, University of Heidelberg, Heidelberg, Germany. Electronic address: holger.haenssle@med.uni-heidelberg.de.
• Sebastian Haferkamp
  Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
• Lucie Heinzerling
  Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.
• Markus V Heppt
  Department of Dermatology, University Hospital Erlangen, University of Erlangen, Erlangen, Germany.
• Franz J Hilke
  Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• Sarah Hobelsberger
  Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany.
• Dieter Krahl
  Private Laboratory of Dermatohistopathology, Mönchhofstraße 52, 69120 Heidelberg.
• Heinz Kutzner
  Dermatopathology Laboratory, Friedrichshafen, Germany.
• Aimilios Lallas
• Konstantinos Liopyris
  Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• Mar Llamas-Velasco
  Department of Dermatology, University Hospital La Princesa, Madrid, Spain.
• Josep Malvehy
  Melanoma Unit, Dermatology Department, Hospital Clínic Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Rarasd (CIBER ER), Instituto de Salud Carlos III, Barcelona, Spain.
• Friedegund Meier
  Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
• Cornelia S L Müller
  Institute for Histology, Cytology and Molecular Diagnostic, Trier, Germany.
• Alexander A Navarini
  Department of Dermatology, University Hospital Basel, Basel, Switzerland.
• Cristian Navarrete-Dechent
  Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Dermatology, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
• Antonio Perasole
  Anatomic and Cytopathology, Az. ULSS 8 Berica, Regione Veneto, Ospedale San Bortolo, Vicenza, Italy.
• Gabriela Poch
  Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• Sebastian Podlipnik
  Department of Dermatology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Ciber de Enfermedades Raras ISCIII, Barcelona, Spain.
• Luis Requena
  Dermatology Department, Hospital Fundación Jiménez Díaz, Madrid, Spain.
• Veronica M Rotemberg
  Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• Andrea Saggini
  Dermatopathology Friedrichshafen, Friedrichshafen, Germany.
• Omar P Sangueza
  Dermatopathology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
• Carlos Santonja
  Pathology Department, Fundación Jiménez Díaz, Madrid, Spain.
• Dirk Schadendorf
  Department of Dermatology, University Hospital Essen, 45147 Essen, Germany.
• Bastian Schilling
  Department of Dermatology, University Hospital Wuerzburg, Wuerzburg, Germany.
• Max Schlaak
  Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
• Justin G Schlager
  Department of Dermatology and Allergology, Ludwig Maximilian University of Munich, Munich, Germany.
• Mildred Sergon
  Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
• Wiebke Sondermann
  Department of Dermatology, University Hospital Essen, Essen, Germany.
• H Peter Soyer
  Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia.
• Hans Starz
  Dermpath München, Munich, Germany.
• Wilhelm Stolz
  Department of Dermatology, Allergology and Environmental Medicine II, Hospital Thalkirchner Street, Munich, Germany.
• Esmeralda Vale
  Department of Dermatology and Dermatopathology, Hospital da Luz, Lisbon, Portugal.
• Wolfgang Weyers
  Center for Dermatopathology, Freiburg, Germany.
• Alexander Zink
  Department of Dermatology and Allergy, Faculty of Medicine, Technical University of Munich, 80802, Munich, Germany.
• Eva Krieghoff-Henning
  Digital Biomarkers for Oncology Group (DBO), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
• Jakob N Kather
  Department of Gastroenterology, University Hospital RWTH Aachen, Aachen, Germany. jakob.kather@gmail.com.
• Christof von Kalle
  National Center for Tumor Diseases, Department of Translational Oncology, German Cancer Research Center, Heidelberg, Germany.
• Daniel B Lipka
  National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
• Stefan Fröhling
  National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
• Axel Hauschild
  Department of Dermatology, University Hospital Kiel, Kiel, Germany.
• Harald Kittler
  ViDIR Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria. Electronic address: harald.kittler@meduniwien.at.at.
• Titus J Brinker
  National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Keywords

External Resources